Brief synopsis: Long ago it was Casemix and DRG funding. Then it became Activity Based Funding (ABF). With the lack of Federal funding support, will ABF even become a centralised method of determining funding in the Australian Public Health Sector? What are the advantages and disadvantages and how does it differ to the funding method in the private sector (MBS, Health Funds and Prostheses List)? What happens when a new technology and associated procedure needs to be introduced into the public sector? What work is being done on the horizon scanning of these new procedures?